Revenue ($USD) : $458,955,000
Revenue (foreign currencies) : €437,100,000
R&D spend : $16,380,000.00
Employees : 1,537
Fiscal year end : 12/31/22
CEO : Francesco Siccardi

Established in 1999 in Switzerland, Medacta specializes in joint replacement, spine surgery, and sports medicine. Beginning with minimally invasive procedures, the company has transitioned to offerings that are personalized for each patient. Medacta operates in over 40 countries. –CN